HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

SKB BIO

523.500

0.000

Volume:435.50K

Turnover:230.72M

Market Cap:125.12B

PE:-270.85

High:542.500

Open:535.000

Low:519.500

Close:523.500

52wk High:581.000

52wk Low:339.600

Shares:239.00M

HK Float Shares:177.00M

Volume Ratio:0.81

T/O Rate:0.25%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-1.933

ROE:2.92%

ROA:0.03%

PB:20.10

PE(LYR):-270.85

PS:51.42

Loading ...

Overview Company News Filings

Movement Alert｜Kelun-Biotech Falls 3.45% in Regular Trading, Profit-Taking After Prior Session Clinical Data Rally

Merck Rises After Partner Kelun-biotech Reports Positive Keytruda Lung Cancer Study

SKB BIO Secures HK$2.7 Billion Placement to Fund R&D, Total Post-IPO Fundraising Approaches HK$7 Billion

China NMPA Clears Kelun-biotech, Harbour Biomed Asthma IND for Skb575/hbm7575

Hbm Holdings - Hbm7575 Co-developed by Harbour Biomed and Kelun-biotech

THOMSON REUTERS

Kelun-biotech and Harbour Biomed Announce Nmpa Approval of Ind Application for Skb575/hbm7575 for the Treatment of Asthma

THOMSON REUTERS

Kelun-Biotech's Lung Cancer Drug Trial Meets Primary Endpoint

MT Newswires Live

Innovative Drug Stocks Surge Following Inclusion in National Essential Medicines List, Accelerating Grassroots Access

Movement Alert｜Kelun-Biotech Rises 10.8% in Regular Trading, Core TROP2 ADC Achieves Phase III Primary Endpoint in PD-L1 Negative NSCLC

Sichuan Kelun-biotech Biopharma Says Primary Endpoint Met for Phase 3 Study of Lung Cancer Treatment

SKB BIO's Pivotal Drug Candidate Achieves Primary Endpoint in Phase 3 Lung Cancer Trial

Kelun-Biotech’s sac-TMT + Keytruda Clears Phase 3 PFS Hurdle in First-Line PD-L1-Negative NSCLC

Bulletin Express

Kelun-biotech Says Phase 3 Sac-tmt Plus Keytruda Meets PFS Endpoint in First-line Pd-l1-negative NSCLC

Sichuan Kelun-biotech Biopharmaceutical - Primary Endpoint Met for Phase 3 Study of Trop2 ADC Sacituzumab Tirumotecan with Pembrolizumab

THOMSON REUTERS

GLMS SEC: Significant Room for Improvement in First-Line Advanced Lung Cancer Treatment; Focus on SKB BIO's Global R&D Progress for sac-TMT

Movement Alert｜Kelun-Biotech Declines 3.17% in Regular Trading, Post-Placement Technical Pullback Continues

Movement Alert｜Kelun-Biotech Biopharmaceutical Intraday Decline 3.1%, Technical Pullback Following Completion of HK$2.72 Billion Share Placement

SKB BIO Releases Updated Articles of Association Following Hong Kong H-Share Listing

Bulletin Express

SKB BIO Completes HK$2.72 Billion H-Share Placement; Core Shareholder’s Stake Eases to 62.53%

Bulletin Express

SKB BIO Completes HKD 2.75 Billion H-Share Placement, Expanding Issued Capital by 3.41%

Bulletin Express

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/stock/06990/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"06990","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06990\",,,,,undefined,":{"symbol":"06990","market":"HK","secType":"STK","nameCN":"SKB BIO","latestPrice":523.5,"timestamp":1787726015692,"preClose":523.5,"halted":0,"volume":435500,"delay":0,"changeRate":0,"floatShares":177000000,"shares":239000000,"eps":-1.932782157091787,"marketStatus":"Trading","change":0,"latestTime":"08-26 14:33:37","open":535,"high":542.5,"low":519.5,"amount":230718300,"amplitude":0.043935,"askPrice":524,"askSize":1000,"bidPrice":523.5,"bidSize":300,"shortable":3,"etf":0,"ttmEps":0.7561861599767943,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1787731800000},"marketStatusCode":2,"adr":0,"listingDate":1689004800000,"exchange":"SEHK","adjPreClose":523.5,"openAndCloseTimeList":[[1787707800000,1787716800000],[1787720400000,1787731200000]],"volumeRatio":0.805975,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06990\",,,,,undefined,":{"symbol":"06990","floatShares":177000000,"roa":"0.03%","roe":"2.92%","lyrEps":-1.932782,"volumeRatio":0.805975,"shares":239000000,"dividePrice":0,"high":542.5,"amplitude":0.043935,"preClose":523.5,"low":519.5,"week52Low":339.6,"pbRate":"20.10","psRate":"51.42","week52High":581,"institutionHeld":0,"latestPrice":523.5,"committee":-0.538462,"eps":-1.932782157091787,"divideRate":0,"volume":435500,"delay":0,"ttmEps":0.7561861599767943,"open":535,"prevYearClose":392.2,"prevWeekClose":538,"prevMonthClose":483.8,"prevQuarterClose":436.2,"fiveDayClose":523.5,"twentyDayClose":497.6,"sixtyDayClose":435.4},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/06990\",params:#limit:5,,,undefined,":[{"date":"2026-08-17","symbol":"06990","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1786930200000,"name":null,"time":"","dateTimestamp":1786896000000,"actualEps":null},{"market":"HK","date":"2026-03-23","symbol":"06990","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774195200000,"reportTimeType":"post","actualEps":null},{"date":"2025-08-18","symbol":"06990","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755480600000,"name":null,"time":"","dateTimestamp":1755446400000,"actualEps":null},{"date":"2025-03-24","symbol":"06990","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742779800000,"name":null,"time":"Post-Mkt","dateTimestamp":1742745600000,"actualEps":null},{"date":"2024-08-19","symbol":"06990","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724031000000,"name":null,"time":"Post-Mkt","dateTimestamp":1723996800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"06990\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"06990\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.4286,"buy":0.5714,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5714,"analysts":21,"updateTime":1786636800000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/06990\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"06990","date":"2026-08-24","current":692.087539,"percent":0.994792,"low":-351.800852,"twenty":-236.660037,"median":-135.707825,"eighty":-53.480935,"high":737.230287,"avg":-136.259184,"sd":108.101526,"marketCap":125009535787},"quantilePoints":[{"date":"2023-07-14","current":-21.13661,"twenty":-21.950454,"median":-21.915957,"eighty":-21.591449,"marketCap":14244687534},{"date":"2023-07-21","current":-23.970152,"twenty":-21.950454,"median":-21.798359,"eighty":-21.186829,"marketCap":16079230625},{"date":"2023-07-28","current":-25.171471,"twenty":-24.928642,"median":-21.953758,"eighty":-21.326081,"marketCap":16867005011},{"date":"2023-08-04","current":-23.795235,"twenty":-24.81024,"median":-23.425444,"eighty":-21.637654,"marketCap":15971316326},{"date":"2023-08-11","current":-25.354634,"twenty":-24.81024,"median":-23.323535,"eighty":-21.856149,"marketCap":16921892522},{"date":"2023-08-18","current":-27.290696,"twenty":-25.136334,"median":-23.811022,"eighty":-21.920213,"marketCap":18083628667},{"date":"2023-08-25","current":-27.955027,"twenty":-25.91111,"median":-24.066367,"eighty":-21.957062,"marketCap":18532979440},{"date":"2023-09-01","current":-41.23344,"twenty":-27.36684,"median":-24.766756,"eighty":-21.989236,"marketCap":16768455673},{"date":"2023-09-08","current":-41.179226,"twenty":-40.625811,"median":-24.994187,"eighty":-22.159386,"marketCap":16549260174},{"date":"2023-09-15","current":-42.756679,"twenty":-41.200358,"median":-25.354634,"eighty":-22.761005,"marketCap":17316444421},{"date":"2023-09-22","current":-42.808543,"twenty":-42.12743,"median":-25.915972,"eighty":-23.169807,"marketCap":17261645546},{"date":"2023-09-29","current":-41.568511,"twenty":-42.347449,"median":-27.197776,"eighty":-23.343916,"marketCap":16790375223},{"date":"2023-10-06","current":-41.914184,"twenty":-42.346401,"median":-27.481057,"eighty":-23.57336,"marketCap":16921892522},{"date":"2023-10-13","current":-45.021843,"twenty":-42.393899,"median":-34.166325,"eighty":-23.80155,"marketCap":18149387317},{"date":"2023-10-20","current":-39.509362,"twenty":-42.529229,"median":-40.304828,"eighty":-23.874674,"marketCap":15902633452},{"date":"2023-10-27","current":-41.923505,"twenty":-42.45246,"median":-40.317099,"eighty":-23.977981,"marketCap":16867093648},{"date":"2023-11-03","current":-44.17615,"twenty":-43.157759,"median":-40.968576,"eighty":-24.032126,"marketCap":17820594068},{"date":"2023-11-10","current":-48.451746,"twenty":-43.729096,"median":-41.213927,"eighty":-24.147781,"marketCap":19541278735},{"date":"2023-11-17","current":-48.422639,"twenty":-44.163404,"median":-41.246315,"eighty":-24.349478,"marketCap":19705675360},{"date":"2023-11-24","current":-47.973827,"twenty":-44.628759,"median":-41.529173,"eighty":-24.780872,"marketCap":19683755810},{"date":"2023-12-01","current":-50.941262,"twenty":-45.174782,"median":-41.90853,"eighty":-24.844962,"marketCap":20987969029},{"date":"2023-12-08","current":-50.880899,"twenty":-46.685504,"median":-41.9817,"eighty":-24.922954,"marketCap":20878371279},{"date":"2023-12-15","current":-53.058458,"twenty":-47.438439,"median":-42.172758,"eighty":-25.124621,"marketCap":21897630350},{"date":"2023-12-22","current":-55.272951,"twenty":-48.26932,"median":-42.355666,"eighty":-25.208104,"marketCap":22796331896},{"date":"2023-12-29","current":-54.398289,"twenty":-48.483234,"median":-42.389893,"eighty":-25.318001,"marketCap":22555216847},{"date":"2024-01-05","current":-54.305497,"twenty":-48.692055,"median":-42.518207,"eighty":-25.505631,"marketCap":22357940898},{"date":"2024-01-12","current":-58.852865,"twenty":-49.706536,"median":-42.808543,"eighty":-25.777515,"marketCap":24243022189},{"date":"2024-01-19","current":-48.649703,"twenty":-50.614438,"median":-43.44751,"eighty":-25.920835,"marketCap":20012549058},{"date":"2024-01-26","current":-45.202208,"twenty":-50.432693,"median":-43.523908,"eighty":-26.320623,"marketCap":18522019665},{"date":"2024-02-02","current":-38.832469,"twenty":-50.323187,"median":-43.65215,"eighty":-26.948338,"marketCap":15891673677},{"date":"2024-02-09","current":-43.972121,"twenty":-49.706536,"median":-43.780393,"eighty":-27.253528,"marketCap":18083628667},{"date":"2024-02-16","current":-51.156498,"twenty":-50.095577,"median":-43.99523,"eighty":-27.328768,"marketCap":21042767904},{"date":"2024-02-23","current":-57.052501,"twenty":-50.855188,"median":-44.095348,"eighty":-27.575851,"marketCap":23344320643},{"date":"2024-03-01","current":-55.517903,"twenty":-51.144997,"median":-44.174132,"eighty":-27.979787,"marketCap":22730573246},{"date":"2024-03-08","current":-62.556972,"twenty":-52.587613,"median":-44.308071,"eighty":-30.229554,"marketCap":25623953833},{"date":"2024-03-15","current":-80.340969,"twenty":-54.14227,"median":-44.794506,"eighty":-38.844663,"marketCap":32879324850},{"date":"2024-03-22","current":-87.812662,"twenty":-54.39157,"median":-45.089055,"eighty":-38.957109,"marketCap":35904222736},{"date":"2024-03-28","current":-54.646477,"twenty":-54.498503,"median":-45.202208,"eighty":-39.211798,"marketCap":33975302345},{"date":"2024-04-05","current":-48.790889,"twenty":-54.557693,"median":-45.399289,"eighty":-39.390336,"marketCap":30314737511},{"date":"2024-04-12","current":-51.407626,"twenty":-54.48688,"median":-46.006494,"eighty":-39.95604,"marketCap":31958703754},{"date":"2024-04-19","current":-48.134373,"twenty":-54.430626,"median":-46.386128,"eighty":-40.284427,"marketCap":29898266063},{"date":"2024-04-26","current":-71.709655,"twenty":-54.881886,"median":-46.751052,"eighty":-40.312191,"marketCap":36824843832},{"date":"2024-05-03","current":-70.050704,"twenty":-55.277405,"median":-46.894686,"eighty":-40.440284,"marketCap":35948061836},{"date":"2024-05-10","current":-80.537958,"twenty":-55.535893,"median":-47.299854,"eighty":-40.706984,"marketCap":41427949311},{"date":"2024-05-17","current":-72.846762,"twenty":-56.640749,"median":-47.434905,"eighty":-40.885351,"marketCap":37416671679},{"date":"2024-05-24","current":-76.490072,"twenty":-57.838988,"median":-47.480121,"eighty":-41.121673,"marketCap":39198277014},{"date":"2024-05-31","current":-74.804992,"twenty":-59.45269,"median":-48.0541,"eighty":-41.186166,"marketCap":38373753847},{"date":"2024-06-07","current":-77.551054,"twenty":-62.567703,"median":-48.422639,"eighty":-41.217553,"marketCap":39733102851},{"date":"2024-06-14","current":-71.048454,"twenty":-63.220056,"median":-48.609184,"eighty":-41.232055,"marketCap":36368156956},{"date":"2024-06-21","current":-75.38559,"twenty":-65.709636,"median":-48.654461,"eighty":-41.23344,"marketCap":38507460307},{"date":"2024-06-28","current":-72.361795,"twenty":-70.050704,"median":-48.790889,"eighty":-41.25919,"marketCap":36947551614},{"date":"2024-07-05","current":-71.32983,"twenty":-70.110492,"median":-48.913989,"eighty":-41.293743,"marketCap":36412725776},{"date":"2024-07-12","current":-64.338068,"twenty":-69.786991,"median":-49.290918,"eighty":-41.483815,"marketCap":32891789012},{"date":"2024-07-19","current":-64.816339,"twenty":-69.10708,"median":-50.290098,"eighty":-41.560643,"marketCap":33136917521},{"date":"2024-07-26","current":-64.836994,"twenty":-68.943217,"median":-50.396598,"eighty":-41.836002,"marketCap":33270623980},{"date":"2024-08-02","current":-67.177788,"twenty":-68.832021,"median":-50.583009,"eighty":-41.911922,"marketCap":34451697705},{"date":"2024-08-09","current":-67.337335,"twenty":-68.832021,"median":-50.91108,"eighty":-41.921641,"marketCap":34763679444},{"date":"2024-08-16","current":-69.468586,"twenty":-68.832021,"median":-51.098991,"eighty":-41.970061,"marketCap":35877899939},{"date":"2024-08-23","current":-143.952492,"twenty":-69.519081,"median":-51.282062,"eighty":-42.023931,"marketCap":36568716645},{"date":"2024-08-30","current":-142.905377,"twenty":-70.543671,"median":-51.775379,"eighty":-42.069838,"marketCap":36546432236},{"date":"2024-09-06","current":-147.713941,"twenty":-71.622574,"median":-52.451442,"eighty":-42.229208,"marketCap":37794359190},{"date":"2024-09-13","current":-159.71572,"twenty":-72.235174,"median":-53.058458,"eighty":-42.319371,"marketCap":40758185707},{"date":"2024-09-20","current":-153.295015,"twenty":-72.624329,"median":-53.663008,"eighty":-42.346401,"marketCap":39354267883},{"date":"2024-09-27","current":-152.378595,"twenty":-73.54444,"median":-54.299669,"eighty":-42.364187,"marketCap":39354267883},{"date":"2024-10-04","current":-188.785359,"twenty":-74.133327,"median":-54.381491,"eighty":-42.385888,"marketCap":48535444762},{"date":"2024-10-10","current":-168.292174,"twenty":-74.96999,"median":-54.488817,"eighty":-42.420555,"marketCap":42986626697},{"date":"2024-10-18","current":-169.261982,"twenty":-75.395206,"median":-54.742682,"eighty":-42.48514,"marketCap":43008911107},{"date":"2024-10-25","current":-173.131782,"twenty":-76.300948,"median":-55.181976,"eighty":-42.60999,"marketCap":43989425142},{"date":"2024-11-01","current":-155.135166,"twenty":-77.964709,"median":-55.298647,"eighty":-42.767052,"marketCap":39443405523},{"date":"2024-11-08","current":-154.553256,"twenty":-78.843611,"median":-55.532894,"eighty":-42.819467,"marketCap":38997717325},{"date":"2024-11-15","current":-143.716763,"twenty":-80.792913,"median":-56.569783,"eighty":-42.897746,"marketCap":35989321988},{"date":"2024-11-22","current":-149.571879,"twenty":-86.542136,"median":-57.071537,"eighty":-43.077872,"marketCap":37437808632},{"date":"2024-11-29","current":-163.214034,"twenty":-139.660525,"median":-57.926605,"eighty":-43.27892,"marketCap":40825038936},{"date":"2024-12-06","current":-164.492389,"twenty":-143.07608,"median":-58.601892,"eighty":-43.427612,"marketCap":41047883035},{"date":"2024-12-13","current":-167.859925,"twenty":-143.961595,"median":-59.46824,"eighty":-43.489321,"marketCap":41805552972},{"date":"2024-12-20","current":-160.518216,"twenty":-146.054141,"median":-61.493522,"eighty":-43.569737,"marketCap":39799956081},{"date":"2024-12-27","current":-154.616488,"twenty":-147.398806,"median":-62.556972,"eighty":-43.707223,"marketCap":38306900618},{"date":"2025-01-03","current":-146.467928,"twenty":-147.580179,"median":-62.909234,"eighty":-43.769457,"marketCap":36323588137},{"date":"2025-01-10","current":-149.189796,"twenty":-147.713941,"median":-63.270129,"eighty":-43.89543,"marketCap":36858413974},{"date":"2025-01-17","current":-146.545949,"twenty":-148.128618,"median":-63.821936,"eighty":-43.999852,"marketCap":36234450497},{"date":"2025-01-24","current":-151.096908,"twenty":-148.795989,"median":-64.223738,"eighty":-44.022873,"marketCap":37593799501},{"date":"2025-01-28","current":-144.751587,"twenty":-148.750633,"median":-64.3181,"eighty":-44.025895,"marketCap":36203787461},{"date":"2025-02-07","current":-162.755483,"twenty":-148.864023,"median":-64.816339,"eighty":-44.095348,"marketCap":40476425278},{"date":"2025-02-14","current":-166.856795,"twenty":-150.654332,"median":-65.202788,"eighty":-44.112421,"marketCap":41476404342},{"date":"2025-02-21","current":-194.414734,"twenty":-151.676932,"median":-65.382992,"eighty":-44.172115,"marketCap":48498984584},{"date":"2025-02-28","current":-211.14481,"twenty":-152.24965,"median":-65.712478,"eighty":-44.17615,"marketCap":52498900839},{"date":"2025-03-07","current":-225.41295,"twenty":-152.905086,"median":-66.309677,"eighty":-44.219461,"marketCap":56271549124},{"date":"2025-03-14","current":-227.151092,"twenty":-153.295015,"median":-66.812487,"eighty":-44.308071,"marketCap":56726085062},{"date":"2025-03-21","current":-236.708664,"twenty":-154.553256,"median":-67.337335,"eighty":-44.550078,"marketCap":59089671940},{"date":"2025-03-28","current":-231.805328,"twenty":-155.61149,"median":-67.803663,"eighty":-44.648429,"marketCap":66180441600},{"date":"2025-04-03","current":-246.46154,"twenty":-156.727441,"median":-67.952396,"eighty":-44.882152,"marketCap":70225812000},{"date":"2025-04-11","current":-242.489155,"twenty":-158.779779,"median":-68.515098,"eighty":-45.005591,"marketCap":68634936000},{"date":"2025-04-17","current":-228.611836,"twenty":-159.44307,"median":-68.80487,"eighty":-45.06217,"marketCap":64862287200},{"date":"2025-04-25","current":-235.137362,"twenty":-160.624501,"median":-68.953584,"eighty":-45.131919,"marketCap":66771338400},{"date":"2025-05-02","current":-274.570331,"twenty":-161.195254,"median":-69.468586,"eighty":-45.197413,"marketCap":78134738400},{"date":"2025-05-09","current":-249.374354,"twenty":-161.514906,"median":-70.050704,"eighty":-45.202208,"marketCap":71462875059},{"date":"2025-05-16","current":-247.507619,"twenty":-162.87029,"median":-70.732965,"eighty":-45.217068,"marketCap":71507400214},{"date":"2025-05-23","current":-244.618313,"twenty":-163.824551,"median":-71.32983,"eighty":-45.58151,"marketCap":70884048033},{"date":"2025-05-30","current":-244.159494,"twenty":-165.025774,"median":-71.669987,"eighty":-45.601984,"marketCap":71062148656},{"date":"2025-06-06","current":-258.187076,"twenty":-166.004403,"median":-72.203519,"eighty":-46.006494,"marketCap":75336563613},{"date":"2025-06-13","current":-271.678883,"twenty":-167.701589,"median":-72.488214,"eighty":-46.133909,"marketCap":79304691313},{"date":"2025-06-20","current":-252.757485,"twenty":-168.349452,"median":-72.789206,"eighty":-46.315126,"marketCap":73636805593},{"date":"2025-06-27","current":-255.806605,"twenty":-169.647858,"median":-73.569836,"eighty":-46.457129,"marketCap":74733815733},{"date":"2025-07-04","current":-283.173205,"twenty":-171.495185,"median":-73.869687,"eighty":-46.685504,"marketCap":82732847998},{"date":"2025-07-11","current":-266.231967,"twenty":-173.142078,"median":-74.539848,"eighty":-46.749361,"marketCap":77704884860},{"date":"2025-07-18","current":-304.526119,"twenty":-187.755426,"median":-75.01675,"eighty":-46.798833,"marketCap":88812112519},{"date":"2025-07-25","current":-289.211949,"twenty":-196.095673,"median":-75.38559,"eighty":-46.877904,"marketCap":84652615741},{"date":"2025-08-01","current":-318.351212,"twenty":-209.071662,"median":-75.715906,"eighty":-46.908544,"marketCap":92605939250},{"date":"2025-08-08","current":-315.832709,"twenty":-214.487876,"median":-76.34536,"eighty":-47.149906,"marketCap":92103142937},{"date":"2025-08-15","current":-340.637946,"twenty":-221.73884,"median":-77.157567,"eighty":-47.354138,"marketCap":99188000086},{"date":"2025-08-22","current":-135.707825,"twenty":-221.73884,"median":-78.335478,"eighty":-47.421279,"marketCap":106638527281},{"date":"2025-08-29","current":-131.473703,"twenty":-217.466422,"median":-78.819337,"eighty":-47.438439,"marketCap":103804584421},{"date":"2025-09-05","current":-151.82862,"twenty":-215.82299,"median":-80.340969,"eighty":-47.449348,"marketCap":119756940196},{"date":"2025-09-12","current":-146.494298,"twenty":-214.791029,"median":-81.555855,"eighty":-47.474394,"marketCap":115757424063},{"date":"2025-09-19","current":-147.466634,"twenty":-214.487876,"median":-85.53437,"eighty":-47.73502,"marketCap":116443055400},{"date":"2025-09-26","current":-143.954691,"twenty":-214.295448,"median":-89.950081,"eighty":-47.938811,"marketCap":113375018127},{"date":"2025-10-03","current":-165.853778,"twenty":-213.463042,"median":-128.34687,"eighty":-48.070155,"marketCap":130933921593},{"date":"2025-10-10","current":-144.531455,"twenty":-212.219938,"median":-131.729362,"eighty":-48.217901,"marketCap":113934664453},{"date":"2025-10-17","current":-135.703716,"twenty":-210.108236,"median":-132.867642,"eighty":-48.374971,"marketCap":106892448189},{"date":"2025-10-24","current":-129.499037,"twenty":-207.014216,"median":-133.546653,"eighty":-48.434282,"marketCap":102042180034},{"date":"2025-10-31","current":-132.379263,"twenty":-204.550971,"median":-132.326202,"eighty":-48.483234,"marketCap":104467314112},{"date":"2025-11-07","current":-120.930715,"twenty":-203.710245,"median":-131.985022,"eighty":-48.610423,"marketCap":95373061321},{"date":"2025-11-14","current":-137.099974,"twenty":-201.138492,"median":-131.729362,"eighty":-48.622244,"marketCap":108431475585},{"date":"2025-11-21","current":-125.836792,"twenty":-194.360264,"median":-130.233026,"eighty":-48.651606,"marketCap":99477134375},{"date":"2025-11-28","current":-134.139839,"twenty":-194.090443,"median":-131.64896,"eighty":-48.675637,"marketCap":106426076251},{"date":"2025-12-05","current":-134.965867,"twenty":-192.863217,"median":-131.473703,"eighty":-48.751223,"marketCap":107265545740},{"date":"2025-12-12","current":-128.449432,"twenty":-188.527876,"median":-130.526276,"eighty":-48.814858,"marketCap":102275366003},{"date":"2025-12-19","current":-122.479247,"twenty":-187.446049,"median":-129.499037,"eighty":-48.911385,"marketCap":97751558204},{"date":"2025-12-24","current":-122.098928,"twenty":-187.290368,"median":-128.758533,"eighty":-48.913338,"marketCap":97751558204},{"date":"2026-01-02","current":-116.223952,"twenty":-179.729041,"median":-128.478737,"eighty":-49.104524,"marketCap":93414299181},{"date":"2026-01-09","current":-137.872108,"twenty":-173.799059,"median":-128.508043,"eighty":-49.251224,"marketCap":111089795631},{"date":"2026-01-16","current":-136.67551,"twenty":-173.152374,"median":-129.252083,"eighty":-49.296233,"marketCap":110483512112},{"date":"2026-01-23","current":-124.044288,"twenty":-172.874196,"median":-128.511935,"eighty":-49.590244,"marketCap":100176692282},{"date":"2026-01-30","current":-119.398299,"twenty":-172.654145,"median":-128.43808,"eighty":-50.08289,"marketCap":96865451522},{"date":"2026-02-06","current":-121.3325,"twenty":-172.20913,"median":-127.906249,"eighty":-50.304899,"marketCap":98684302080},{"date":"2026-02-13","current":-119.328264,"twenty":-171.604872,"median":-127.229577,"eighty":-50.349599,"marketCap":97611646623},{"date":"2026-02-20","current":-118.929435,"twenty":-171.385498,"median":-126.777731,"eighty":-50.372821,"marketCap":97145274685},{"date":"2026-02-27","current":-109.393801,"twenty":-170.608939,"median":-126.362178,"eighty":-50.420375,"marketCap":90336244390},{"date":"2026-03-06","current":-109.941252,"twenty":-169.952459,"median":-125.237252,"eighty":-50.5225,"marketCap":90056421227},{"date":"2026-03-13","current":-111.874188,"twenty":-169.826622,"median":-125.028422,"eighty":-50.583009,"marketCap":92061820561},{"date":"2026-03-20","current":-118.784792,"twenty":-169.647858,"median":-124.510593,"eighty":-50.752344,"marketCap":97378460654},{"date":"2026-03-27","current":-246.717525,"twenty":-170.608939,"median":-124.791344,"eighty":-50.880899,"marketCap":106705913600},{"date":"2026-04-02","current":-270.1664,"twenty":-172.638036,"median":-125.053164,"eighty":-50.929189,"marketCap":117409151000},{"date":"2026-04-10","current":-262.507699,"twenty":-173.162671,"median":-125.237252,"eighty":-50.974222,"marketCap":114960698000},{"date":"2026-04-17","current":-276.768173,"twenty":-188.270393,"median":-126.362178,"eighty":-51.053793,"marketCap":121256720000},{"date":"2026-04-24","current":-263.25072,"twenty":-199.457552,"median":-126.777731,"eighty":-51.109685,"marketCap":115341038016},{"date":"2026-04-30","current":-249.758244,"twenty":-207.783795,"median":-127.598017,"eighty":-51.131881,"marketCap":109457493848},{"date":"2026-05-08","current":-237.123047,"twenty":-214.424086,"median":-128.140667,"eighty":-51.206724,"marketCap":104280765336},{"date":"2026-05-15","current":-230.895214,"twenty":-220.549694,"median":-128.478737,"eighty":-51.422215,"marketCap":101808994065},{"date":"2026-05-22","current":-251.35436,"twenty":-225.355554,"median":-129.00513,"eighty":-51.539533,"marketCap":110576786499},{"date":"2026-05-29","current":-244.039033,"twenty":-227.151092,"median":-129.499037,"eighty":-51.775379,"marketCap":107731917678},{"date":"2026-06-05","current":-207.501784,"twenty":-227.151092,"median":-130.526276,"eighty":-51.91711,"marketCap":91735360204},{"date":"2026-06-12","current":-219.148588,"twenty":-226.740676,"median":-131.473703,"eighty":-52.267792,"marketCap":96818814328},{"date":"2026-06-18","current":-218.939992,"twenty":-226.404961,"median":-131.824218,"eighty":-52.561632,"marketCap":96958725910},{"date":"2026-06-26","current":-221.178526,"twenty":-225.594566,"median":-132.326202,"eighty":-52.73121,"marketCap":97471735042},{"date":"2026-07-03","current":-263.841103,"twenty":-227.197711,"median":-132.771691,"eighty":-52.93717,"marketCap":116359798531},{"date":"2026-07-10","current":-273.42961,"twenty":-228.864297,"median":-133.50718,"eighty":-53.148078,"marketCap":120440552988},{"date":"2026-07-17","current":-263.005613,"twenty":-229.666754,"median":-134.182751,"eighty":-53.480935,"marketCap":116261258521},{"date":"2026-07-24","current":-277.867014,"twenty":-230.754675,"median":-134.677954,"eighty":-54.022455,"marketCap":122858320066},{"date":"2026-07-31","current":-261.04507,"twenty":-231.704791,"median":-134.965867,"eighty":-54.274788,"marketCap":115639796202},{"date":"2026-08-07","current":-290.535115,"twenty":-235.013451,"median":-135.70577,"eighty":-54.298503,"marketCap":128953431275},{"date":"2026-08-14","current":-279.9487,"twenty":-236.676246,"median":-136.101797,"eighty":-54.329175,"marketCap":124411975864},{"date":"2026-08-21","current":729.337059,"twenty":-236.676246,"median":-135.748112,"eighty":-53.902639,"marketCap":128594895322},{"date":"2026-08-24","current":709.257694,"twenty":-236.660037,"median":-135.707825,"eighty":-53.480935,"marketCap":125009535787}],"updateTime":1787687493106},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"06990\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1108708574","title":"Movement Alert｜Kelun-Biotech Falls 3.45% in Regular Trading, Profit-Taking After Prior Session Clinical Data Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=1108708574","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108708574?lang=en_us&edition=fundamental","pubTime":"2026-07-16 10:06","pubTimestamp":1784167581,"startTime":"0","endTime":"0","summary":"On July 16, Kelun-Biotech (06990.HK) declined 3.45% in regular trading, trading at HK$519.5/share, with turnover of HK$125 million. The stock opened up over 4% before rapidly retreating, displaying a...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651970463","title":"Merck Rises After Partner Kelun-biotech Reports Positive Keytruda Lung Cancer Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2651970463","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651970463?lang=en_us&edition=fundamental","pubTime":"2026-07-15 20:38","pubTimestamp":1784119100,"startTime":"0","endTime":"0","summary":"BUZZ-Merck rises after partner Kelun-Biotech reports positive Keytruda lung cancer studyUpdates** Shares of drugmaker MerckMRK.Ngains 2.59% to $123.91 premarket** Partner Kelun-Biotech on Tuesday said a late-stage study of its experimental cancer drug sac-TMT in combination with Merck's Keytruda met the main goal in first-line advanced lung cancer patients whose tumors lacked PD-L1 expression** Kelun says the combination helped patients live longer without their disease worsening versus Keytruda plus chemotherapy and showed a positive trend toward overall survival** The study is the first late-stage trial of an antibody-drug conjugate and immunotherapy combination to meet its main goal in this first-line lung cancer setting, according to Kelun**The data support the potential for sac-TMT plus Keytruda to challenge current standard-of-care regimens across a broader first-line lung cancer population - Leerink Partners analyst Akash Tewari** Separately, MRKon Wednesday saidits cancer drug ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nL4N43H13X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BLSP4239.USD","LU1571399168.USD","BK4007","LU1934455863.HKD","LU1989772840.SGD","SG9999013999.USD","LU2361044865.SGD","IE00BFTCPJ56.SGD","LU0203347892.USD","LU0980610538.SGD","LU2112291526.USD","LU0432979614.USD","LU2491049909.HKD","LU0859254822.USD","LU1093756325.SGD","LU1923622614.USD","PAWZ","SGXZ57979304.SGD","LU1162221912.USD","FHLC","LU1934455194.USD","LU1430594728.SGD","IE00BBT3K403.USD","LU0124676726.USD","LU2125909247.SGD","SG9999001440.SGD","LU0965509283.SGD","LU2125909593.SGD","LU0265550359.USD","LU2089984988.USD","LU2125154935.USD","IE00B4R5TH58.HKD","LU2491050071.SGD","SG9999015341.SGD","LU0868494708.USD","BMED","MRK","LU0289739699.SGD","IE0009355771.USD","LU0098860793.USD","LU0196878994.USD","LU1941712348.USD","LU1037948541.HKD","LU1989771016.USD","SG9999002232.USD","LU0265550946.USD","LU2357627491.SGD","LU2023250504.SGD","GDOC","IXJ","XLV","LU1699723380.USD","BK4588","LU0006306889.USD","LU0211331839.USD","LU0861579265.USD","RXL","LU2461242641.AUD","LU1941712264.USD","LU0965508806.USD","BK1161","JDOC","BK4585","LU0477156953.USD","LU1066051225.USD","BK4516","LU1035773651.USD","LU0234572021.USD","SG9999015358.SGD","SG9999014567.USD","LU2361045086.USD","LU1066053197.SGD","LU1929549753.HKD","IE0002141913.USD","IE00BJJMRZ35.SGD","06990","LU1934455277.USD","IE00B1BXHZ80.USD","SG9999014559.SGD","LU2361044949.HKD","PPH","LU0965509010.AUD","LU1037948897.HKD","LU1989772923.USD","BK4550","LU0689626769.HKD","LU0203345920.USD","SG9999014542.SGD","LU0965509101.SGD","LU2491050154.USD","BK4533","LU1201861249.SGD","LU0130102774.USD","IE00B2B36J28.USD","LU2324357040.USD","LU1116320737.USD","LU1291159041.SGD","LU1061106388.HKD","SG9999014575.USD","LU0058720904.USD","LU0106261372.USD","LU0985320562.USD","BK4559","IE00BN8TJ469.HKD","LU0208291251.USD","LU1057294990.SGD","LU0238689110.USD","IE000M9KFDE8.USD","HRTS","LU2468319806.SGD","LU0130517989.USD","LU1069347547.HKD","SG9999001176.USD","LU1023059063.AUD","FTXH","SG9999002224.SGD","LU1974910355.USD","BK4534","LU0648001328.SGD","LU2023250843.SGD","IE00BJT1NW94.SGD","IE00BLSP4452.SGD","LU1066051498.USD","LU0868494617.USD","LU2433249047.HKD","SG9999001176.SGD","IYH","LU2106854487.HKD","LU0122379950.USD","IHE","LU0320765646.SGD","LU2125154778.USD","VHT","LU1983299246.USD","LU2360032135.SGD","LU0320765489.SGD","LU0070302665.USD","LU1116320901.HKD","IE00BSNM7G36.USD","LU0942090050.USD","LU1093756168.USD","LU1585245621.USD","LU0266013472.USD","LU1917777945.USD","LU1066051811.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191169154","title":"SKB BIO Secures HK$2.7 Billion Placement to Fund R&D, Total Post-IPO Fundraising Approaches HK$7 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=1191169154","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191169154?lang=en_us&edition=fundamental","pubTime":"2026-07-15 19:01","pubTimestamp":1784113298,"startTime":"0","endTime":"0","summary":"On July 10, SKB BIO (06990.HK) announced the successful completion of a new H-share placement, raising net proceeds of approximately HK$2.723 billion.This innovative biotech company, which listed...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990","LU0196878994.USD","IPOS","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651451920","title":"China NMPA Clears Kelun-biotech, Harbour Biomed Asthma IND for Skb575/hbm7575","url":"https://stock-news.laohu8.com/highlight/detail?id=2651451920","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651451920?lang=en_us&edition=fundamental","pubTime":"2026-07-15 18:02","pubTimestamp":1784109748,"startTime":"0","endTime":"0","summary":"China NMPA clears Kelun-Biotech, Harbour BioMed asthma IND for SKB575/HBM7575China’s NMPA cleared an IND for SKB575/HBM7575, a long-acting bispecific antibody for asthma.The drug is co-developed by Ke","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nNDL9mBrfs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1979443071.USD","BK0060","06990","LU0196878994.USD","LU1064130708.USD","LU1064131003.USD","LU1934453819.USD","BK0239","002422","LU2148510915.USD","BK1583","BK1574","02142","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651451667","title":"Hbm Holdings - Hbm7575 Co-developed by Harbour Biomed and Kelun-biotech","url":"https://stock-news.laohu8.com/highlight/detail?id=2651451667","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651451667?lang=en_us&edition=fundamental","pubTime":"2026-07-15 18:00","pubTimestamp":1784109651,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nFWN43H0F9:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["06990","LU0196878994.USD","BK1583","BK1574","02142","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651451612","title":"Kelun-biotech and Harbour Biomed Announce Nmpa Approval of Ind Application for Skb575/hbm7575 for the Treatment of Asthma","url":"https://stock-news.laohu8.com/highlight/detail?id=2651451612","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651451612?lang=en_us&edition=fundamental","pubTime":"2026-07-15 18:00","pubTimestamp":1784109604,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nTUABBJB5T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["06990","LU0196878994.USD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651436131","title":"Kelun-Biotech's Lung Cancer Drug Trial Meets Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2651436131","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651436131?lang=en_us&edition=fundamental","pubTime":"2026-07-15 11:46","pubTimestamp":1784087219,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical's  phase 3 study of sacituzumab tirumotecan  combined with Merck's Keytruda met the primary endpoint in first-line treatment of PD-L1-negative advanced non-squamous non-small cell lung cancer, according to a Wednesday Hong Kong bourse filing.The study showed the combination significantly improved progression-free survival compared with pembrolizumab plus chemotherapy.An interim analysis also indicated a positive trend in overall survival, while no new safety signals were identified.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["06990","LU0196878994.USD","XBI","BK4588","BK4585","BK1161","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101227446","title":"Innovative Drug Stocks Surge Following Inclusion in National Essential Medicines List, Accelerating Grassroots Access","url":"https://stock-news.laohu8.com/highlight/detail?id=1101227446","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101227446?lang=en_us&edition=fundamental","pubTime":"2026-07-15 10:56","pubTimestamp":1784084190,"startTime":"0","endTime":"0","summary":"Shares of innovative drug companies are leading gains in the Hong Kong market.SKB BIO (06990) rose 10.5% to HK$550.5, while INNOVENT BIO (01801) gained 8.38% to HK$97.6. AKESO (09926) advanced 7.88%...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0540923850.HKD","LU0196878994.USD","LU2476274720.SGD","159992","LU0417516571.SGD","BK1574","LU0348827113.USD","IE00BPRC5H50.USD","BK4585","IBBQ","LU0417516738.SGD","BK4588","LU2097828805.USD","BK1589","LU2097828631.EUR","LU1720050803.USD","LU2242644610.SGD","LU0348825331.USD","LU0417516902.SGD","LU1794554557.SGD","LU0348767384.USD","LU2097828714.EUR","LU0634319403.HKD","LU0348735423.USD","IE00B5MMRT66.SGD","LU2097828557.USD","LU0348766576.USD","LU0348784397.USD","VXUS","KURE","LU2488822045.USD","01530","LU2476274308.USD","LU2778985437.USD","LU0455707207.USD","LU1961090484.USD","KCAI","IE00B543WZ88.USD","BK1583","LU2399975544.HKD","LU0502904849.HKD","06990","LU0348783233.USD","HK0000165453.HKD","BK1593","LU1969619763.USD","LU2328871848.SGD","01801","MEDX","06978","BK1161","LU2097828474.EUR","LU0561508036.HKD","09926"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102600985","title":"Movement Alert｜Kelun-Biotech Rises 10.8% in Regular Trading, Core TROP2 ADC Achieves Phase III Primary Endpoint in PD-L1 Negative NSCLC","url":"https://stock-news.laohu8.com/highlight/detail?id=1102600985","media":"Market Focus","labels":["productRelease","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102600985?lang=en_us&edition=fundamental","pubTime":"2026-07-15 10:39","pubTimestamp":1784083181,"startTime":"0","endTime":"0","summary":"On July 15, Kelun-Biotech (06990.HK) rose 10.8% in regular trading to HK$552.0, with turnover of HK$465 million.The rally was driven by the company announcing that its core product sacituzumab...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651480077","title":"Sichuan Kelun-biotech Biopharma Says Primary Endpoint Met for Phase 3 Study of Lung Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2651480077","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651480077?lang=en_us&edition=fundamental","pubTime":"2026-07-15 09:20","pubTimestamp":1784078400,"startTime":"0","endTime":"0","summary":"BRIEF-Sichuan Kelun-Biotech Biopharma Says Primary Endpoint Met For Phase 3 Study Of Lung Cancer TreatmentJuly 15 (Reuters)-Sichuan Kelun-Biotech Biopharmaceutical Co Ltd6990.HK:PRIMARY ENDPOINT MET F","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nFWN43G19N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","LU0196878994.USD","06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197384924","title":"SKB BIO's Pivotal Drug Candidate Achieves Primary Endpoint in Phase 3 Lung Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=1197384924","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197384924?lang=en_us&edition=fundamental","pubTime":"2026-07-15 07:44","pubTimestamp":1784072678,"startTime":"0","endTime":"0","summary":"SKB BIO (ASX: 06990) has announced that its Phase 3 clinical trial for the combination therapy of its core TROP2-targeting antibody-drug conjugate (ADC), sac-TMT (also known as SKB264/MK-2870), with...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PD","LU1169589451.USD","BK4023","BK1161","LU1169590202.USD","06990","LU0196878994.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119756156","title":"Kelun-Biotech’s sac-TMT + Keytruda Clears Phase 3 PFS Hurdle in First-Line PD-L1-Negative NSCLC","url":"https://stock-news.laohu8.com/highlight/detail?id=1119756156","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119756156?lang=en_us&edition=fundamental","pubTime":"2026-07-15 07:40","pubTimestamp":1784072440,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (Kelun-Biotech) announced that an Independent Data Monitoring Committee has confirmed the Phase 3 OptiTROP-Lung06 trial met its primary endpoint. The...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651482461","title":"Kelun-biotech Says Phase 3 Sac-tmt Plus Keytruda Meets PFS Endpoint in First-line Pd-l1-negative NSCLC","url":"https://stock-news.laohu8.com/highlight/detail?id=2651482461","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651482461?lang=en_us&edition=fundamental","pubTime":"2026-07-15 07:24","pubTimestamp":1784071455,"startTime":"0","endTime":"0","summary":"Kelun-Biotech says Phase 3 sac-TMT plus Keytruda meets PFS endpoint in first-line PD-L1-negative NSCLCSichuan Kelun-Biotech reported its Phase 3 OptiTROP-Lung06 study met the primary endpoint of progr","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nNDLbLHStv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990","BK1161","LU0196878994.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651431482","title":"Sichuan Kelun-biotech Biopharmaceutical - Primary Endpoint Met for Phase 3 Study of Trop2 ADC Sacituzumab Tirumotecan with Pembrolizumab","url":"https://stock-news.laohu8.com/highlight/detail?id=2651431482","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651431482?lang=en_us&edition=fundamental","pubTime":"2026-07-15 07:23","pubTimestamp":1784071412,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nFWN43G19N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0196878994.USD","06990","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143660492","title":"GLMS SEC: Significant Room for Improvement in First-Line Advanced Lung Cancer Treatment; Focus on SKB BIO's Global R&D Progress for sac-TMT","url":"https://stock-news.laohu8.com/highlight/detail?id=1143660492","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143660492?lang=en_us&edition=fundamental","pubTime":"2026-07-14 15:30","pubTimestamp":1784014245,"startTime":"0","endTime":"0","summary":"A recent report from GLMS SEC highlights that substantial opportunities for advancement remain in the first-line treatment of advanced lung cancer. This is due to limited survival benefits for many...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B5MMRT66.SGD","LU1119993845.HKD","IE00BZ08YT58.USD","BK1557","LU0431992006.USD","IE00BYV24P56.USD","161027","IE00BZ08YS42.EUR","LU2476274308.USD","IE0008369823.USD","06690","BK1214","LU0593848301.USD","IE00BMCWC346.EUR","IE0034224299.USD","IE00B031HY20.USD","LU0196878994.USD","IE00BZ08YR35.GBP","IE0008368742.USD","BK1161","01456","LU2279701549.SGD","LU0877626530.USD","LU0205439572.USD","601456","BK1147","06990","BK0276","LU0868486357.SGD","LU0862451753.SGD","LU0890818403.SGD","IE00B29SXG58.USD","LU2778985437.USD","IE00BPRC5H50.USD","LU0640798160.USD","BK1564","LU1115378108.SGD","IE00B543WZ88.USD","LU1655091616.SGD","LU2048586759.USD","BK1607"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152270577","title":"Movement Alert｜Kelun-Biotech Declines 3.17% in Regular Trading, Post-Placement Technical Pullback Continues","url":"https://stock-news.laohu8.com/highlight/detail?id=1152270577","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152270577?lang=en_us&edition=fundamental","pubTime":"2026-07-14 10:05","pubTimestamp":1783994702,"startTime":"0","endTime":"0","summary":"On July 14, Kelun-Biotech fell 3.17% in regular trading, trading at HK$500.5/share, with turnover of HK$135 million.On the news front, the company completed a placement of 5.838 million new H shares...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128287343","title":"Movement Alert｜Kelun-Biotech Biopharmaceutical Intraday Decline 3.1%, Technical Pullback Following Completion of HK$2.72 Billion Share Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=1128287343","media":"Market Focus","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128287343?lang=en_us&edition=fundamental","pubTime":"2026-07-13 09:47","pubTimestamp":1783907233,"startTime":"0","endTime":"0","summary":"On July 13, Kelun-Biotech Biopharmaceutical fell 3.1% in regular trading, trading at HK$489.2/share, with turnover of HK$208 million. The decline represents a technical correction following a sharp...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109702331","title":"SKB BIO Releases Updated Articles of Association Following Hong Kong H-Share Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=1109702331","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109702331?lang=en_us&edition=fundamental","pubTime":"2026-07-10 17:22","pubTimestamp":1783675372,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (SKB BIO) has published its revised Articles of Association, now effective after the company’s 11 July 2023 debut on the Hong Kong Stock Exchange...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173568073","title":"SKB BIO Completes HK$2.72 Billion H-Share Placement; Core Shareholder’s Stake Eases to 62.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=1173568073","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173568073?lang=en_us&edition=fundamental","pubTime":"2026-07-10 17:22","pubTimestamp":1783675346,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (SKB BIO) has closed its previously announced H-share placement, issuing 5.84 million new shares at HK$470.20 each. All terms under the placing...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180080507","title":"SKB BIO Completes HKD 2.75 Billion H-Share Placement, Expanding Issued Capital by 3.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=1180080507","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180080507?lang=en_us&edition=fundamental","pubTime":"2026-07-10 17:22","pubTimestamp":1783675345,"startTime":"0","endTime":"0","summary":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (SKB BIO) confirmed the completion of a private placing of 5.84 million new H shares on 10 July 2026. The shares were issued at HKD 470.20 each,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06990"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200,"code":"91000000","status":"200"}]}}